What does peripheral blood eosinophilia (elevated eosinophil count in the peripheral blood) mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Peripheral blood eosinophilia is defined as an absolute eosinophil count greater than 0.5 x 10^9/L in blood, according to the most recent and highest quality study 1.

Definition and Classification

Peripheral blood eosinophilia refers to an abnormally high level of eosinophils, a type of white blood cell, in the peripheral blood. This condition occurs when the body produces more eosinophils in response to various triggers. Eosinophils play a role in fighting parasitic infections and are involved in allergic reactions and inflammatory processes.

Causes and Management

Common causes of peripheral blood eosinophilia include:

  • Allergic disorders (such as asthma, hay fever, drug allergies)
  • Parasitic infections
  • Certain medications
  • Autoimmune disorders
  • Hematologic malignancies The management of peripheral blood eosinophilia depends on identifying and treating the underlying cause. Persistent unexplained eosinophilia warrants further investigation as it may indicate a more serious condition requiring specific treatment.

Key Points

  • Eosinophilia can be classified as mild, moderate, or severe based on the absolute eosinophil count.
  • Hypereosinophilia (HE) is defined as persistent elevated eosinophil count ≥1.5 x 10^9/L in blood and/or tissue.
  • The classification and definition of HE and related syndromes have been proposed by an international consensus proposal, which includes hereditary (familial), primary (clonal/neoplastic), secondary (reactive), and HE of undetermined significance variants 1.
  • The management of HE and related syndromes depends on the underlying cause and may involve targeted therapies, such as imatinib for patients with PDGFRA rearrangement 1.

From the Research

Definition of Peripheral Blood Eosinophilia

  • Peripheral blood eosinophilia is defined as an absolute count of > 500 eosinophils per mm3 of peripheral blood 2
  • It can also be defined as a peripheral blood eosinophil count greater than 1.0 × 10^9 /L 3 or 1.5 × 10^9 /L 4
  • Eosinophilia is associated with many disorders, limiting its usefulness as a diagnostic tool in screening for parasite infections 2

Causes of Peripheral Blood Eosinophilia

  • Fungal allergy, parasitic infection, and severe eosinophilic asthma are common causes of peripheral blood eosinophilia 3
  • Hypereosinophilic syndrome (HES) disease, including eosinophilic granulomatosis with polyangiitis (EGPA), is a less common cause 3
  • Other causes include myeloproliferative disease, lymphocyte-variant hypereosinophilic syndrome, and idiopathic hypereosinophilic syndrome 4

Diagnosis and Management

  • Diagnosis of peripheral blood eosinophilia relies on morphologic review of the blood and marrow, standard cytogenetics, fluorescence in situ hybridization, next generation sequencing gene assays, and flow immunophenotyping 4
  • A semi-structured algorithm can be used to determine the underlying diagnosis 3
  • Treatment options include corticosteroids, hydroxyurea, interferon-α, and targeted therapies such as imatinib and mepolizumab 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Eosinophilia caused by parasites.

Pediatric annals, 1994

Research

The causes of a peripheral blood eosinophilia in a secondary care setting.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.